The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Antibiotic Resistance and the MRSA Problem
Open accessAbstract
Staphylococcus aureus is capable of becoming resistant to all classes of antibiotics clinically available and resistance can develop through de novo mutations in chromosomal genes or through acquisition of horizontally transferred resistance determinants. This review covers the most important antibiotics available for treatment of S. aureus infections and a special emphasis is dedicated to the current knowledge of the wide variety of resistance mechanisms that S. aureus employ to withstand antibiotics. Since resistance development has been inevitable for all currently available antibiotics, new therapies are continuously under development. Besides development of new small molecules affecting cell viability, alternative approaches including anti-virulence and bacteriophage therapeutics are being investigated and may become important tools to combat staphylococcal infections in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increasing prevalence of fluoroquinolone resistance in S. aureus, particularly MRSA, presents significant challenges in clinical settings.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [238]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
"Celbenin" - resistant Staphylococci
Jevons, M. P. (1961) · BMJ · doi:10.1136/bmj.1.5219.124-a · Cited by 1,680
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008 · cited 2×
“…and transported to the division septum of the growing cell, where the structural similarity between penicillin and D -alanyl- D -alanine ( D -ala- D -ala) residues of newly synthesized UDP-MurNAc-penta, allows penicillin to inhibit crosslinking of peptidoglycan by acting as a substrate analog (6).”
BackgroundIto, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1323-1336.2001 · Cited by 963
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Holden, M. T. G., Feil, E. J., Lindsay, J. A., Peacock, S. J., Day, N. P. J., Enright, M. C., Foster, T. J., Moore, C. E., Hurst, L., Atkin, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402521101 · Cited by 892
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
(2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00579-09 · Cited by 804
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 800
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Mechanisms of Methicillin Resistance in Staphylococcus aureus
Peacock, S. J., & Paterson, G. K. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034516 · Cited by 656
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Bradley, P., Gordon, N. C., Walker, T. M., Dunn, L., Heys, S., Huang, B., Earle, S., Pankhurst, L. J., Anson, L., de Cesare, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10063 · Cited by 556
Cellbenin-resistant staphylococci.
Jevons, M. P. (1961) · Medical Entomology and Zoology · Cited by 555
Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
RifamycinMode of Action, Resistance, and Biosynthesis
Floss, H. G., & Yu, T.-W. (2005) · Chemical Reviews · doi:10.1021/cr030112j · Cited by 547
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP
Barna, J. C. J., & Williams, D. H. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.002011 · Cited by 528
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Tenover, F. C., McDougal, L. K., Goering, R. V., Killgore, G., Projan, S. J., Patel, J. B., & Dunman, P. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.1.108-118.2006 · Cited by 524
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. M. M. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M.-N., Ploy, M.-C., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 492
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
The history of the tetracyclines
Nelson, M. L., & Levy, S. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06354.x · Cited by 468
Mayville, P., Ji, G., Beavis, R., Yang, H., Goger, M., Novick, R. P., & Muir, T. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1218 · Cited by 455
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Ribosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449
Lim, D., & Strynadka, N. C. J. (2002) · Nature Structural Biology · doi:10.1038/nsb858 · Cited by 442
Tomasz, A. (1979) · Annual Review of Microbiology · doi:10.1146/annurev.mi.33.100179.000553 · Cited by 433
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Glycopeptide resistance in enterococci
ARTHUR, M., REYNOLDS, P., & COURVALIN, P. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 414
Evidence for a Clonal Origin of Methicillin Resistance in Staphylococcus aureus
Kreiswirth, B., Kornblum, J., Arbeit, R. D., Eisner, W., Maslow, J. N., McGeer, A., Low, D. E., & Novick, R. P. (1993) · Science · doi:10.1126/science.8093647 · Cited by 409
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Kehrenberg, C., & Schwarz, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1156-1163.2006 · Cited by 398
Plasmid-linked Resistance to Inorganic Salts in Staphylococcus aureus
Novick, R. P., & Roth, C. (1968) · Journal of Bacteriology · doi:10.1128/jb.95.4.1335-1342.1968 · Cited by 393
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Pinho, M. G., de Lencastre, H., & Tomasz, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191260798 · Cited by 384
Michalopoulos, A. S., Livaditis, I. G., & Gougoutas, V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.07.007 · Cited by 378
Howden, B. P., McEvoy, C. R. E., Allen, D. L., Chua, K., Gao, W., Harrison, P. F., Bell, J., Coombs, G., Bennett-Wood, V., Porter, J. L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002359 · Cited by 370
Ernst, C. M., Staubitz, P., Mishra, N. N., Yang, S.-J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 368
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
Hanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
Cunha, B. A. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70309-6 · Cited by 358
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Kehrenberg, C., Schwarz, S., Jacobsen, L., Hansen, L. H., & Vester, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04754.x · Cited by 333
The emerging problem of linezolid-resistant Staphylococcus
Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J., & Humphries, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks354 · Cited by 332
Linezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Frees, D., Chastanet, A., Qazi, S., Sørensen, K., Hill, P., Msadek, T., & Ingmer, H. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04368.x · Cited by 327
Self-citationKahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Harkins, C. P., Pichon, B., Doumith, M., Parkhill, J., Westh, H., Tomasz, A., de Lencastre, H., Bentley, S. D., Kearns, A. M., & Holden, M. T. G. (2017) · Genome Biology · doi:10.1186/s13059-017-1252-9 · Cited by 323
Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2276-2285.2000 · Cited by 318
Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin
Giesbrecht, P., Kersten, T., Maidhof, H., & Wecke, J. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1371-1414.1998 · Cited by 304
Factors influencing methicillin resistance in staphylococci
Berger-Bächi, B., & Rohrer, S. (2002) · Archives of Microbiology · doi:10.1007/s00203-002-0436-0 · Cited by 301
MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus
Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2395-2405.2005 · Cited by 296
Mechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
Morales, G., Picazo, J. J., Baos, E., Candel, F. J., Arribi, A., Peláez, B., Andrade, R., de la Torre, M., Fereres, J., & Sánchez‐García, M. (2010) · Clinical Infectious Diseases · doi:10.1086/650574 · Cited by 292
Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci
Tomasz, A., Nachman, S., & Leaf, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.124 · Cited by 291
Campbell, J., Singh, A. K., Santa Maria, J. P., Kim, Y., Brown, S., Swoboda, J. G., Mylonakis, E., Wilkinson, B. J., & Walker, S. (2011) · ACS Chemical Biology · doi:10.1021/cb100269f · Cited by 289
Otero, L. H., Rojas-Altuve, A., Llarrull, L. I., Carrasco-López, C., Kumarasiri, M., Lastochkin, E., Fishovitz, J., Dawley, M., Hesek, D., Lee, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300118110 · Cited by 281
Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power
de Lencastre, H., Oliveira, D., & Tomasz, A. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.08.003 · Cited by 278
Mascio, C. T. M., Alder, J. D., & Silverman, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-07 · Cited by 276
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 276
Transfer of Antibiotic Resistance in Staphylococcus aureus
Haaber, J., Penadés, J. R., & Ingmer, H. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.011 · Cited by 265
Self-citationShen, J., Wang, Y., & Schwarz, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt092 · Cited by 258
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Paharik, A. E., Parlet, C. P., Chung, N., Todd, D. A., Rodriguez, E. I., Van Dyke, M. J., Cech, N. B., & Horswill, A. R. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.001 · Cited by 244
Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam Antibiotics
Tan, C. M., Therien, A. G., Lu, J., Lee, S. H., Caron, A., Gill, C. J., Lebeau-Jacob, C., Benton-Perdomo, L., Monteiro, J. M., Pereira, P. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003592 · Cited by 241
Cui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-M., Maruyama, T., Horikawa, Y., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.428-438.2006 · Cited by 240
Peleg, A. Y., Miyakis, S., Ward, D. V., Earl, A. M., Rubio, A., Cameron, D. R., Pillai, S., Moellering, R. C., & Eliopoulos, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028316 · Cited by 236
Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance
Gaynor, M., & Mankin, A. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452159 · Cited by 235
McAleese, F., Petersen, P., Ruzin, A., Dunman, P. M., Murphy, E., Projan, S. J., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1865-1871.2005 · Cited by 233
Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 227
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 226
Novick, R. P., & Richmond, M. H. (1965) · Journal of Bacteriology · doi:10.1128/jb.90.2.467-480.1965 · Cited by 225
Howden, B. P., Johnson, P. D. R., Ward, P. B., Stinear, T. P., & Davies, J. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00422-06 · Cited by 224
Mendes, R. E., Deshpande, L. M., & Jones, R. N. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.04.002 · Cited by 221
Meehl, M., Herbert, S., Götz, F., & Cheung, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-07 · Cited by 216
An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H.-M., Camargo, I. L. B. D. C., Watanabe, Y., Shoji, M., Hishinuma, T., & Hiramatsu, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00437-10 · Cited by 206
Locke, J. B., Hilgers, M., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-09 · Cited by 205
Wisplinghoff, H., Rosato, A. E., Enright, M. C., Noto, M., Craig, W., & Archer, G. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3574-3579.2003 · Cited by 203
Genetics of Antimicrobial Resistance in Staphylococcus Aureus
Jensen, S. O., & Lyon, B. R. (2009) · Future Microbiology · doi:10.2217/fmb.09.30 · Cited by 202
Structure and function of the dihydropteroate synthase from staphylococcus aureus
Hampele, I. C., D’Arcy, A., Dale, G. E., Kostrewa, D., Nielsen, J., Oefner, C., Page, M. G. P., Schönfeld, H.-J., Stüber, D., & Then, R. L. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0944 · Cited by 201
Prunier, A., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J., & Leclercq, R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374937 · Cited by 199
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 199
Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype
Pillai, S. K., Sakoulas, G., Wennersten, C. B., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345368 · Cited by 193
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli
Takahata, S., Ida, T., Hiraishi, T., Sakakibara, S., Maebashi, K., Terada, S., Muratani, T., Matsumoto, T., Nakahama, C., & Tomono, K. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.011 · Cited by 191
Geiger, T., Kästle, B., Gratani, F. L., Goerke, C., & Wolz, C. (2014) · Journal of Bacteriology · doi:10.1128/jb.01201-13 · Cited by 190
Genomic Basis for Methicillin Resistance in Staphylococcus aureus
Hiramatsu, K., Ito, T., Tsubakishita, S., Sasaki, T., Takeuchi, F., Morimoto, Y., Katayama, Y., Matsuo, M., Kuwahara-Arai, K., Hishinuma, T., et al. (2013) · Infection & Chemotherapy · doi:10.3947/ic.2013.45.2.117 · Cited by 189
LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus
Floyd, J. L., Smith, K. P., Kumar, S. H., Floyd, J. T., & Varela, M. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-10 · Cited by 188
Resistance to and synthesis of the antibiotic mupirocin
Thomas, C. M., Hothersall, J., Willis, C. L., & Simpson, T. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2278 · Cited by 187
Zhanel, G. G., Love, R., Adam, H., Golden, A., Zelenitsky, S., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Rubinstein, E., Walkty, A., et al. (2015) · Drugs · doi:10.1007/s40265-015-0352-7 · Cited by 187
The emergence of clinical resistance to tigecycline
Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 185
Wu, S., Piscitelli, C., de LENCASTRE, H., & Tomasz, A. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.435 · Cited by 185
Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
Mensa, B., Howell, G. L., Scott, R., & DeGrado, W. F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02955-14 · Cited by 185
Howden, B. P., & Grayson, M. L. (2006) · Clinical Infectious Diseases · doi:10.1086/499365 · Cited by 182
Sieradzki, K., & Tomasz, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7103-7110.2003 · Cited by 181
Berg, T., Firth, N., Apisiridej, S., Hettiaratchi, A., Leelaporn, A., & Skurray, R. A. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4350-4359.1998 · Cited by 174
Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
Saravolatz, L. D., Stein, G. E., & Johnson, L. B. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir147 · Cited by 173
Besier, S. M., Ludwig, A., Zander, J., Brade, V., & Wichelhaus, T. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01098-07 · Cited by 169
Wu, S. W., de Lencastre, H., & Tomasz, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.8.2417-2424.2001 · Cited by 167
MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus
Seah, C., Alexander, D. C., Louie, L., Simor, A. E., Low, D. E., Longtin, J., & Melano, R. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05325-11 · Cited by 166
Staphylococcal cassette chromosome mec: Recent advances and new insights
Shore, A. C., & Coleman, D. C. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.002 · Cited by 165
Kehrenberg, C., Cuny, C., Strommenger, B., Schwarz, Š., & Witte, W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01376-08 · Cited by 161
Are pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 160
Murakami, K., & Tomasz, A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.2.874-879.1989 · Cited by 158
Macrolides and lincosamides in cattle and pigs: Use and development of antimicrobial resistance
Pyörälä, S., Baptiste, K. E., Catry, B., van Duijkeren, E., Greko, C., Moreno, M. Á., Pomba, C., Rantala, M. H. J., Ružauskas, M., Sandérs, P., et al. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.02.028 · Cited by 151
Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus
Huang, J., O’Toole, P. W., Shen, W., Amrine‐Madsen, H., Jiang, X., Lobo, N. A., Palmer, L. M., Voelker, L. L., Fan, F., Gwynn, M. N., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.909-917.2004 · Cited by 151
Mechanism of Action of Streptogramins and Macrolides
Vannuffel, P., & COCITO, C. G. (1996) · Drugs · doi:10.2165/00003495-199600511-00006 · Cited by 147
Bal, A. M., Coombs, G. W., Holden, M. T. G., Lindsay, J. A., Nimmo, G. R., Tattevin, P., & Skov, R. L. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.04.004 · Cited by 147
Chatterjee, I., Kriegeskorte, A., Fischer, A., Deiwick, S., Theimann, N., Proctor, R. A., Peters, G., Herrmann, M., & Kahl, B. C. (2007) · Journal of Bacteriology · doi:10.1128/jb.00912-07 · Cited by 145
Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-09 · Cited by 145
Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids
Pader, V., Hakim, S., Painter, K. L., Wigneshweraraj, S., Clarke, T. B., & Edwards, A. M. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.194 · Cited by 142
Kadlec, K., Feßler, A. T., Hauschild, T., & Schwarz, S. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03842.x · Cited by 140
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302109200 · Cited by 139
McKay, G. A., Beaulieu, S., Arhin, F. F., Belley, A. C., Sarmiento, I., Parr, T., & Moeck, G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp126 · Cited by 138
Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
Kim, S. J., Cegelski, L., Stueber, D., Singh, M., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.031 · Cited by 134
Zhu, W., Murray, P. R., Huskins, W. C., Jernigan, J. A., McDonald, L. C., Clark, N. C., Anderson, K. F., McDougal, L. K., Hageman, J., Olsen-Rasmussen, M. A., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-10 · Cited by 132
Hu, Q., Peng, H., & Rao, X. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01601 · Cited by 132
Genetic Basis of Resistance to Fusidic Acid in Staphylococci
O’Neill, A. J., McLaws, F., Kahlmeter, G., Henriksen, A. S., & Chopra, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-06 · Cited by 130
Daum, R. S., Gupta, S., Sabbagh, R., & Milewski, W. M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.5.1066 · Cited by 130
The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
Beabout, K., Hammerstrom, T. G., Perez, A. M., Magalhães, B. D. F., Prater, A. G., Clements, T. P., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-15 · Cited by 129
Penicillin Resistant Staphylococci
Bondi, A., & Dietz, C. C. (1945) · Experimental Biology and Medicine · doi:10.3181/00379727-60-15089 · Cited by 128
Nielsen, A., Månsson, M., Bojer, M. S., Gram, L., Larsen, T. O., Novick, R. P., Frees, D., Frøkiær, H., & Ingmer, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084992 · Cited by 126
Self-citationForty years of beta-lactam research
Rolinson, G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.6.589 · Cited by 125
Daigle, D. M., Hughes, D. W., & Wright, G. D. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80006-4 · Cited by 125
Bertsche, U., Weidenmaier, C., Kühner, D., Yang, S., Baur, S., Wanner, S., François, P., Schrenzel, J., Yeaman, M. R., & Bayer, A. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01226-10 · Cited by 125
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus
O’Neill, A. J., Cove, J. H., & Chopra, I. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.647 · Cited by 123
Rémy, J., Tow-Keogh, C. A., McConnell, T., D'Alton, J., & DeVito, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks307 · Cited by 123
Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA
Hososaka, Y., Hanaki, H., Endo, H., Suzuki, Y., Nakae, T., Nagasawa, Z., Otsuka, Y., & Sunakawa, K. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0502-7 · Cited by 122
Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline
Fluit, A. C., Florijn, A., Verhoef, J., & Milatović, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1636-1638.2005 · Cited by 122
Kim, C. K., Mwangi, M. M., Chung, M., Milheiriço, C., de LENCASTRE, H., & Tomasz, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082814 · Cited by 121
Howden, B. P., Smith, D. J., Mansell, A. S., Johnson, P. D. R., Ward, P. B., Stinear, T. P., & Davies, J. K. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-39 · Cited by 121
Boyle‐Vavra, S., Labischinski, H., Ebert, C. C., Kerstin Ehlert, B., & Daum, R. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.280-287.2001 · Cited by 118
Streptogramins – Two are better than one!
Mast, Y., & Wohlleben, W. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.08.008 · Cited by 117
Vancomycin-intermediate resistance in Staphylococcus aureus
Hiramatsu, K., Kayayama, Y., Matsuo, M., Aiba, Y., Saito, M., Hishinuma, T., & Iwamoto, A. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.04.006 · Cited by 117
The bactericidal action of penicillin: new clues to an unsolved mystery
Bayles, K. W. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01762-5 · Cited by 116
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002505 · Cited by 116
Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters?
Reynolds, E. C. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00218-8 · Cited by 114
Bæk, K. T., Gründling, A., Mogensen, R. G., Thøgersen, L., Petersen, A., Paulander, W., & Frees, D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02802-14 · Cited by 112
Self-citationO’Neill, A. J., Larsen, A. R., Skov, R. L., Henriksen, A. S., & Chopra, I. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01984-06 · Cited by 111
Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus
Wichelhaus, T. A., Böddinghaus, B., Besier, S. M., Schäfer, V., Brade, V., & Ludwig, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3381-3385.2002 · Cited by 111
Mechanism of quinolone resistance in Staphylococcus aureus
Tanaka, M., Wang, T., Onodera, Y., Uchida, Y., & Sato, K. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070010 · Cited by 107
Norström, T., Lannergård, J., & Hughes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00328-07 · Cited by 107
Smith, J. R., Roberts, K. D., & Rybak, M. J. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0077-7 · Cited by 106
Falagas, M. E., Ρούσσος, Ν., Gkegkes, I. D., Rafailidis, P. I., & Karageorgopoulos, D. E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902967624 · Cited by 106
Bayer, A. S., Mishra, N. N., Chen, L., Kreiswirth, B. N., Rubio, A., & Yang, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00970-15 · Cited by 105
Tedizolid for the Management of Human Infections: In Vitro Characteristics
Locke, J. B., Zurenko, G. E., Shaw, K. J., & Bartizal, K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit616 · Cited by 101 · cited 1×
“Fortunately, tedizolid, a second-generation oxazolidinone, retains activity against strains carrying cfr (168).”
BackgroundKosowska-Shick, K., Clark, C., Pankuch, G. A., McGhee, P., Dewasse, B. E., Beachel, L., & Appelbaum, P. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-09 · Cited by 101
Antibodies for the treatment of bacterial infections: current experience and future prospects
Bebbington, C. R., & Yarranton, G. T. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.002 · Cited by 100
Werth, B. J., Jain, R., Hahn, A. W., Cummings, L. A., Weaver, T., Waalkes, A., SenGupta, D. J., Salipante, S. J., Rakita, R. M., & Butler‐Wu, S. M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.028 · Cited by 100
Bertsche, U., Yang, S., Kühner, D., Wanner, S., Mishra, N. N., Roth, T., Nega, M., Schneider, A. T., Mayer, C., Grau, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067398 · Cited by 99
Evidence for the evolutionary steps leading to mecA-mediated β-lactam resistance in staphylococci
Rolo, J., Worning, P., Nielsen, J. B., Sobral, R. G., Bowden, R. J., Bouchami, O., Damborg, P., Guardabassi, L., Perreten, V., Westh, H., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006674 · Cited by 99
Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Takahashi, Y., & Igarashi, M. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.117 · Cited by 98
Tigecycline: a novel glycylcycline antibiotic
Zhanel, G. G., Karlowsky, J. A., Rubinstein, E., & Hoban, D. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.9 · Cited by 97
Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance
Karlowsky, J. A., Nichol, K. A., & Zhanel, G. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ534 · Cited by 96
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
Françoise Van Bambeke, A. (2015) · Drugs · doi:10.1007/s40265-015-0505-8 · Cited by 92
Vestergaard, M. R., Nøhr-Meldgaard, K., Bojer, M. S., Nielsen, C. K., Meyer, R. L., Slavetinsky, C. J., Peschel, A., & Ingmer, H. (2017) · mBio · doi:10.1128/mbio.01114-17 · Cited by 92
Self-citationDiep, B. A., Afasizheva, A., Le, H. N., Kajikawa, O., Matute‐Bello, G., Tkaczyk, C., Sellman, B. R., Badiou, C., Lina, G., & Chambers, H. F. “. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit129 · Cited by 90
Prunier, A., Malbruny, B., Tandé, D., Picard, B., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3054-3056.2002 · Cited by 90
Boyle‐Vavra, S., Carey, R. B., & Daum, R. S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.5.617 · Cited by 88
Antibiotic Management of Staphylococcus aureus Infections in US Children's Hospitals, 1999–2008
Herigon, J. C., Hersh, A. L., Gerber, J. S., Zaoutis, T. E., & Newland, J. G. (2010) · PEDIATRICS · doi:10.1542/peds.2009-2867 · Cited by 86
Tigecycline: A new glycylcycline antimicrobial agent
Kasbekar, N. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050487 · Cited by 86
Mwangi, M. M., Kim, C. K., Chung, M., et al. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0053 · Cited by 83
Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Kerstin Ehlert, B., Labischinski, H., & Wilkinson, B. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3749-3757.2004 · Cited by 83
Matsuo, M., Cui, L., Kim, J., & Hiramatsu, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-13 · Cited by 83
Gentry, D. R., Rittenhouse, S. F., McCloskey, L., & Holmes, D. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01066-06 · Cited by 83
Investigational drugs to treat methicillin-resistantStaphylococcus aureus
Vuong, C., Yeh, A. J., Cheung, G. Y. C., & Otto, M. J. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1109077 · Cited by 81
Characterization of Global Patterns and the Genetics of Fusidic Acid Resistance
Farrell, D. J., Castanheira, M., & Chopra, I. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir164 · Cited by 79
Roberts, A. A., Sharma, S. V., Strankman, A., Duran, S. R., Rawat, M., & Hamilton, C. J. (2013) · Biochemical Journal · doi:10.1042/bj20121541 · Cited by 79
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 870
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Silva, K. P. T., Sundar, G., & Khare, A. (2023) · Nature Communications · doi:10.1038/s41467-023-38507-4 · Cited by 44
de Souza, A. Á., Lima, A. M., dede Oliveira BezerraSousa, D., Nogueira, F. C., do Sacramento Neto, J. C., Dias, L. P., Araújo, N. M. S., Nagano, C. S., Júnior, H. V. N., da Silva, C. R., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09979-5 · Cited by 8
Metadata
- Authors
- Vestergaard, M., Frees, D., & Ingmer, H.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2019-04-12
- Volume
- 7
- Issue
- 2
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2923656972
- Cited by
- 490
- References
- 253
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.